ClinicalTrials.Veeva

Menu

Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study (COVID-19)

U

University of Cagliari

Status

Completed

Conditions

Seroprevalence
SARS-CoV Infection
Covid19

Treatments

Diagnostic Test: Antibodies testing

Study type

Observational

Funder types

Other

Identifiers

NCT04839913
COVID-SER

Details and patient eligibility

About

The investigator analyzed the data of the patients admitted to the surgical department during the period 1St September - 10Th December 2020 to estimate the seroprevalence of SARS-CoV-2 infection in the setting of a non-dedicated COVID-19 hospital and in a mild CoV-2 incidence area and to evaluate the difference of seroprevalence between Spring and Fall seasons in a cohort of patients undergoing surgery.

Enrollment

121 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient admitted to our unit who had performed SARS-COV-2 serologic test

Exclusion criteria

  • age < 18

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems